Identification of two candidate tumor suppressor genes on chromosome 17p13.3

Cancer Research

Volumn 56, Issue 9, 1996, Pages 1997-2002

  Schultz, David C ^a   Vanderveer, Lisa ^a   Berman, David B ^a   Hamilton, Thomas C ^a   Wong, Albert J ^b   Godwin, Andrew K ^a  

^a FOX CHASE CANCER CENTER   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BRAIN TUMOR; BREAST TUMOR; CAENORHABDITIS ELEGANS; CARCINOGENESIS; CHROMOSOME 17P; CHROMOSOME LOSS; CHROMOSOME MAP; GENE EXPRESSION REGULATION; GENE LOCATION; HUMAN; HUMAN CELL; LUNG TUMOR; MOLECULAR CLONING; NORTHERN BLOTTING; OVARY TUMOR; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE; TUMOR SUPPRESSOR GENE;

ALLELES; AMINO ACID SEQUENCE; CHROMOSOME DELETION; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 17; FEMALE; GENES, TUMOR SUPPRESSOR; GENETIC MARKERS; HUMANS; MOLECULAR SEQUENCE DATA; OVARIAN NEOPLASMS; RATS; TUMOR CELLS, CULTURED;

EID: 0029877208     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Godwin, A. K., Schultz, D. C., Hamilton, T, C., and Knudson, A. G. Oncogenes and tumor suppressor genes. In: W. J. Hoskins, C. A. Perez, and R C. Young (eds.), Gynecological Oncology. Principles and Practice. Philadelphia: J. B. Lippincott Company, in press, 1996.
2. Sato, T., Saito, H., Morita, R., Koi, S., Lee, J. H., and Nakamura, Y. Allelotype of human ovarian cancer. Cancer Res , 51: 5118-5122, 1991.
3. Yang-Feng, T. L., Han, H , Chen, K-C., Li, S-b., Claus, E. B , Carcangiu, M. L., Chambers, S K., Chambers, J. T., and Schwartz, P. E. Allelic loss in ovarian cancer. Int. J Cancer, 54. 546-541, 1993.
4. Cliby, W , Ritland, S., Hartman, L., Dodson, M , Halling, K. C., Keeney, G., Podratz, K C., and Jenkins, R. B Human epithelial ovarian cancer allelotype. Cancer Res., 53 2393-2398, 1993.
5. Osborne, R. J., and Leech, V. PCR allelotyping of human ovarian cancers. Br. J. Cancer, 69: 429-438, 1994.
6. Foulkes, W D., Black, D M., Stamp, G. W. H., Solomon, E. and Trowsdale, J Very frequent loss of heterozygosity throughout chromosome 17 in sporadic ovarian carcinoma. Int. J Cancer, 54. 220-225, 1993.
7. Phillips, N., Ziegler, M., SaHa, B , and Xynos, F Allelic loss on chromosome 17 in human ovarian cancer Int. J Cancer, 54: 85-91, 1993
8. Godwin, A. K., Vanderveer, L , Schultz, D. C., Lynch, H. T., Altomare, D. A., Buetow, K. H , Daly, M., Getts, L. A., Masny, A., Rosenblum, N., Hogan, M , Ozols, R. F., and Hamilton, T. C. A common region of deletion on chromosome 17q in both sporadic and familial epithelial ovarian tumors distal to BRCA1. Am J. Hum. Genet., 55: 666-677, 1994
9. Phillips, N. J., Ziegler, M. R., Radford, D. M , Fair, K. L., Steinbrueck, T , Xynos, F P , and Donis-Keller, H. Allelic deletion on chromosome 17p13.3 in early ovarian cancer Cancer Res., 56: 606-611, 1996.
10. Coles, C., Thompson, A. M., Elder, P. A., Cohen, B. B , Mackenzie, I. M , Cranston, G., Chetty, U , Mackay, J., MacDonald, M., Nakamura, Y., Hoyheim, B., and Steel, C. M. Evidence implicating at least two genes on chromosome 17p in breast carcinogenesis. Lancet, 336: 761-763, 1990.
11. Cornelis, R. S., van Vliet, M., Vos, C. B. J , Cleton-Jansen, A-M., van de Vijver, M. J., Peterse, J. L., Khan, P. M., Borresen, A-L , Cornelisse, C. J., and Devilee, P. Evidence for a gene on 17p13.3, distal to TP53 as a target for allele loss in breast tumors without p53 mutations Cancer Res., 54. 4200-4206, 1994.
12. Biegel, J. A , Burk, C D , Barr, F G , and Emanuel, B S Evidence for a 17p tumor locus distinct from p53 in pediatric primitive neuroectodermal tumors. Cancer Res., 52: 3391-3395, 1992.
13. Atkin, N. B., and Baker, M. C Chromosome 17p loss in carcinoma of the cervix uteri. Cancer Genet. Cytogenet., 37: 229-233, 1989.
14. Cogen, P. H., Daneshvar, L., Metzger, A. K., Duyk, G., Edwards, M. S. B., and Sheffield, V. C. Involvement of multiple chromosome 17p loci in medulloblastoma tumorigenesis. Am. J. Hum. Genet., 50 584-589, 1992
15. Saylors, R., Sidransky, D., Friedman, H. S , Bigner, S. H , Bigner, D. D., Vogelstein, B., and Brodeur, G. M. Infrequent p53 gene mutations in medulloblastomas. Cancer Res., 51: 4721-4723, 1991.
16. Toguchida, J., Ishizaki, K., Nakamura, Y., Sasaki, M. S , Ikenaga, M., Kato, M., Sugimoto, M., Kotoura, Y., and Yamamuro, T. Assignment of a common allele loss in osteosarcoma to the subregion 17p13. Cancer Res. 49: 6247-6251, 1989.
17. Saxena, A., Clark, W. C. Robertson, J. T., Ikejri, B., Oldfield, E H., and Ali, I. Evidence for the involvement of a potential second tumor suppressor gene on chromosome 17 distinct from p53 in malignant atrocytomas. Cancer Res., 52: 6716-6721, 1992.
18. Schultz, D. C., Vanderveer, L., Buetow, K. H., Boente, M. P., Ozols, R. F., Hamilton, T. C., and Godwin, A. K. Characterization of chromosome 9 in human ovarian neoplasia identifies frequent genetic imbalance on 9q and rare alterations involving 9p, including CDKN2. Cancer Res., 55. 2150-2157, 1995.
19. Ledbetter, D. H., Ledbetter, S. A., vanTuinen, P., Summers, K. M., Robinson, T. J., Nakamura, Y , Wolff, R., White, R., Barker, D. F., Wallace, M. R., Collins, F. S., and Dobyns, W. B. Molecular dissection of a contiguous gene syndrome, frequent submicroscopic deletions, evolutionary conserved sequences, and a hypomethylated "island" in the Miller-Dieker chromosome region. Proc Natl. Acad. Sci USA, 86: 5136-5140, 1989.
20. Gypay, G., Morissette, J , Vignal, A., Dib, C., Fizames, C., Millasseau, P., Marc, S., Bernardi, G., Lathrop, M., and Weissenbach, J. The 1993-94 Généthon human genetic linkage map. Nat. Genet., 7: 246-339, 1994
21. Jones, M., H and Nakamura, Y. Detection of loss of heterozygosity at the human TP53 locus using a dinucleotide repeat polymorphism. Genes Chromosomes & Cancer, 5. 89-90, 1992
22. Oliphant, A, R., Wright, E. C., Swensen, J., Gruis, N. A., Goldgar, D., and Skolnick, M. H. Dinucleotide repeat polymorphism at the D17S513 locus. Nucleic Acids Res., 19: 4794, 1993.
23. Murray, J. C., Buetow, K. H., Weber, J L., Ludwigsen, S., Scherpbier-Heddema, T., Manion, F., Quillen, J., Sheffield, V. C., Sunden, S., Duyk, G. M., Weissenbach, J , Gyapay, G., Dib, C., Morissette, J., Lathrop, G. M., Vignal, A., White, R , Matsunami, N., Gerken, S., Melis, R., Albertsen, H., Plaetke, R., Odelberg, S , Ward, D., Dausset, J., Cohen, D., and Cunn, H. A comprehensive human linkage map with centiMorgan density. Cooperative Human Linkage Center (CHLC). Science (Washington DC), 205: 2049-2054, 1994.
24. Lee, N. H., Weinstock, K. G., Kirkness, E F., Earle-Hughes, J. A , Fuldner, R. A., Marmaras, S., Glodek, A., Gocayne, J. D , Adams, M. D , Kerlavage, A. R., Fraser, C. M., and Venter, J. C. Comparative expressed sequence tag analysis of differential gene expression profiles in PC-12 cells before and after nerve growth factor treatment. Proc. Natl. Acad. Sci., 92: 8303-8307, 1995.
25. Hosking, L., Trowsdale, J., Nicolai, H., Solomon, E., Foulkes, W., Stamp, G., Signer, E., and Jeffreys, A. A somatic BRCA1 mutation in an ovarian tumor. Nat. Genet , 9: 343-344, 1995.
26. Merajver, SD. Pham, T. M., Caduff, R. F., Chen, M., Poy, E. L., Cooney, K. A., Weber, B. L., Collins, F. S., Johnston, C , and Frank, T S Somatic mutations in the BRCA1 gene in sporadic ovarian tumors Nat Genet., 9: 439-443, 1995.
27. Zheng, J , Benedict, W. F., Xu. H-J., Hu, S-X , Kim, T. M , Velicescu, M., Wan, M., Cofer, K. F , and Dubeau, L. Genetic disparity between morphologically benign cysts contiguous to ovarian adenocarcinomas and solitary cystadenomas. J. Natl Cancer Inst., 87: 1146-1153, 1995.
28. Wilson, R., Ainscough, R., Andersen, K., Baynes, C., Berks, M., Bonfield, J., Burton, J., Connell, M , Copsey, T., Cooper, J , Coulson, A , Craxton, M., Dear, S., Du, Z , Durbin, R., Favello, A., Fulton, L., Gardner, A., Green, P., Hawkins, T., Hillier, L , Jier, M., Johnston, L., Jones, M., Kershaw, J , Kirsten, J., Laister, N., Latrielle, P., Lightning, J , Lloyd, C., McMurray, A., Mortimore, B., O'Callaghan, M., Parsons, J , Percy, C., Rifken, L , Roopra, A., Saunders, D., Shownkeen, R , Smaldon, N., Smith, A., Sonnhammer, E., Staden, R., Sulston, J., Thierry-Mieg, J., Thomas, K., Vaudin, M., Vaughan, K., Waterston, R., Watson, A., Weinstock, L , Wilkinson-Sproat, J., and Wohldman, P. 2.2Mb of contiguous nucleotide sequence from chromosome III of C. elegans. Nature (Lond.). 368: 32-38, 1994.
29. Mattheakis, L. C., Sor, F., and Collier, R. J. Diphthamide synthesis in Saccharomyces cerevisiae: structure of the DPH2 gene. Gene. 132: 149-154, 1993.
30. Iglewski, W. J. Cellular ADP-ribosylation of elongation factor 2. Mol. Cell. Biochem., 138: 131-133, 1994
31. Herman, J. G., Latif, F., Weng, Y., Lerman, M., Zbar, B., Liu, S , Samid, D , Duan, D-S. R., Gnarra, J R , Linehan, W. M., and Baylin, S. B. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma Proc Natl Acad Sci. USA, 91: 9700-9704, 1994.
32. Merlo, A., Herman, J. G., Mao, L., Lee, D. J., Gabrielson, E., Burger, P C., Baylin, S. B., and Sidransky, D 5′ CpG island methylation is associated with transcriptional silencing of the tumor suppressor p16/CDKN2/MTS1 in human cancers. Nat. Med., 1: 686-692, 1995
33. Makos, M., Nelkin, B. D., Chazin, V. R., Cavenee, W. K., Brodeur, G., and Baylin, S. B. DNA hypermethylation is associated with 17p allelic loss in neural tumors. Cancer Res., 53: 2715-2718, 1993.
34. Pieretti, M., Powell, D. E., Gallion, H. H , Conway, P. S , Case, E. A., and Turker. M. S. Hypermethylation at a chromosome 17 "hot spot" is a common event in ovarian cancer. Hum. Pathol., 26: 398-401, 1995
35. Wales, M M , Biel, M A , Deiry, W E , Nelkin, B. D., Issa, J-P , Cavenne, W. K., Kuerbitz, S. J., and Baylin, S. B p53 activates expression of HIC-1, a new candidate tumor suppressor gene on 17p13.3 Nat. Med., 1, 570-577, 1995